No description available.

Yes / Peripheral nerve injuries affect a large proportion of the global population, often causing significant morbidity and loss of function. Current treatment strategies include the use of implantable nerve guide conduits (NGC's) to direct regenerating axons between the proximal and distal ends of the nerve gap. However, NGC's are limited in their effectiveness at promoting regeneration Current NGCs are not suitable as substrates for supporting either neuronal or Schwann cell growth, as they lack an architecture similar to that of the native extracellular matrix (ECM) of the nerve. The aim of this study was to create an acellular porcine peripheral nerve using a novel decellularisation protocol, in order to eliminate the immunogenic cellular components of the tissue, while preserving the three-dimensional histoarchitecture and ECM components. Porcine peripheral nerve (sciatic branches were decellularised using a low concentration (0.1%; w/v) sodium dodecyl sulphate in conjunction with hypotonic buffers and protease inhibitors, and then sterilised using 0.1% (v/v) peracetic acid. Quantitative and qualitative analysis revealed a ≥95% (w/w) reduction in DNA content as well as preservation of the nerve fascicles and connective tissue. Acellular nerves were shown to have retained key ECM components such as collagen, laminin and fibronectin. Slow strain rate to failure testing demonstrated the biomechanical properties of acellular nerves to be comparable to fresh controls. In conclusion, we report the production of a biocompatible, biomechanically functional acellular scaffold, which may have use in peripheral nerve repair. / Engineering and Physical Sciences Research Council. Grant Number: EPSRC EP/F500513/1

Neurofibromatosis Type II (NF2) is a neurological disorder arising from mutations in the rif2 gene. NF2 is characterized by formation of bilateral vestibular schwannomas. These tumors arise from Schwann cells, the myelin-forming glia in nerves. Schwannoma cells lose the characteristic bipolar, spindle morphology and assume a round fibroblast-like phenotype. Phenotypic de-differentiation of schwannomas has been attributed to increased levels of Cdc42/Rac-GTP and activation of downstream pathways. The n/2 gene encodes the tumor suppressor called merlin. It is targeted to the plasma membrane by direct binding to paxillin at paxillin-binding domain 1, encoded by exon 2 of the nj2 gene. At the plasma membrane, merlin associates with B1-integrin and erbB2/3 receptors and actin regulating proteins. We hypothesize that merlin modulates actin polymerization, and thus cell shape, by controlling the activity of actin filament regulating proteins. We developed an in vitro model ofNF2 using ad-ere ( ad-Cre) viral mediated deletion of nj2 exon 2 in primary mouse Schwann cells. Within 5 days of ad-Cre infection, merlin levels fall to 40% of normal levels in Schwann cells. Moreover, the expressed merlin protein has the expected lower molecular weight and does not target to the plasma membrane. Schwann cells expressing this mutant merlin lose their characteristic bipolar shape. We tested the activation levels of2 candidate Cdc42/Rac dependent-actin regulating proteins in these cells. Using immunofluorescence, we found that the activity of these proteins increased dramatically within 4 days of n/2 inactivation. This increase in activity was then confirmed with western blotting. We conclude that the function of these actin-filament regulating proteins could contribute to changes in morphology associated with schwannoma formation in NF2.

The nervous system, including the brain, is the most sophisticated organ in the mammalian body. In such a complex network, neuron-glial interaction is essential and controls most developmental processes, such as stem cell fate determination, migration, differentiation, synapse formation, ensheathment and myelination. Many of these events are critical for the developmental process and small errors can lead to growth retardation, malformation or disease. The understanding of the normal progress of nervous system development is fundamental and will help the discovery of new treatments for disease. This thesis discusses three types of neuron-glia interactions at different developmental stages; neural stem/progenitor cell (NSPC) differentiation, building and maintaining the structure of the sciatic nerve, and myelin formation. In Paper I we show that NSPCs, based upon their morphology and expression of specific protein markers, have the capacity to differentiate into cells of either the peripheral nervous system (PNS) or enteric nervous system (ENS) when grown with PNS or ENS primary cell cultures, or fed with conditioned medium from these. This indicates that soluble factors secreted from the PNS or ENS cultures are important for stem cell differentiation and fate determination. The adhesion protein neuronal cadherin (N-cadherin) is implicated in migration, differentiation and nerve outgrowth in the developing PNS. In Paper II N-cadherin was exclusively found in ensheathing glia (nonmyelinating Schwann cells, satellite cells and enteric glia) in contact with each other or with axons. Functional blocking of N-cadherin in dissociated fetal dorsal root ganglia (DRG) cultures led to a decrease in attachment between Schwann cells. N-cadherin-mediated adhesion of nonmyelinating Schwann cells may be important in encapsulating thin calibre axons and provide support to myelinating Schwann cells. In Paper III the inhibitory gamma aminobutyric acid (GABA) and GABAB receptors were studied in the Schwann cell of the adult sciatic nerve and DRG cultures. GABAB receptors were primarily expressed in nonmyelinating Schwann cells and protein levels decreased during development and myelination. Blocking the GABAB receptor in long-term DRG cultures led to decreased levels of mRNA markers for myelin. These results indicate that the GABA and GABAB receptors may be involved in Schwann cell myelination.

Electrical stimulation of tissues induces cell alignment, directed migration, extended processes, differentiation, and proliferation, but the mechanisms involved remain largely unknown. To reveal effects of electric fields (EF) through the media on cell behavior, voltage (7.45 – 22 V), current density (36 – 106 mA/cm2), duration (2 – 24 hrs), and alternating currents (AC, 2 – 1000 Hz) were varied independently when exposed to cell cultures. It was determined that current density and duration are the primary attribute Schwann cells respond to when an EF is applied through the media. This implies that the number of charges moving across the cell surface may play a key role in EF-induced changes in cell behavior. Identical conditions were used to stimulate cells grown on the surface of a conductive substrate to examine if a scaffold can provide structural and EF cues. The effects of an EF through the substrate were examined by placing a protein gel on the surface during stimulation and observing the morphology of subsequent cell cultures and the physical topology of the gel. EFs were shown to create Ca2+ redistribution across gels and subtle changes in collagen I fibril banding. Stimulated gels were able to induce perpendicular Schwann cell alignment on newly seeded cultures days after initial EF exposure, and the cell response decreased when seeded at longer times, indicating the effects of EF on the matrix environment has a relaxation time. These findings were then integrated into a biodegradable, electrically conductive polypyrrole-poly-ε-caprolactone polymer developed by collaborators. Dorsal root ganglia placed in matrix gels on top of conducting polymer exhibited significantly longer axons when stimulated with DC and AC signals. The overall results demonstrate that EFs have a significant effect on the extracellular environment. The broad implication of this data grants researchers with the ability to physically and metabolically control cell behavior with EFs, including improved wound healing or reduced cancer metastasis. / text

No description available.

No description available.

京都大学 / 新制・課程博士 / 博士(薬科学) / 甲第23141号 / 薬科博第140号 / 新制||薬科||15(附属図書館) / 京都大学大学院薬学研究科薬科学専攻 / (主査)教授 金子 周司, 教授 髙倉 喜信, 准教授 中川 貴之 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

No description available.

No description available.